Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertension

NCT00352430 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

NIH

Sponsor class

Conditions

Pulmonary Hypertension

Interventions

DRUG: Nitric Oxide/INP Pulse Delivery
DRUG: Nitric Oxide/INO Pulse Delivery

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)